تجاوز إلى المحتوى الرئيسي
User Image

حمد بن مسفر القحطاني

Associate Professor

عضو هيئة تدريس

كلية الصيدلة
2 أ 144
المنشورات
فصل كتاب
2019

Chapter Six - Thiouracil: Comprehensive profile

Alkahtani, Nasr Y Khalil, Haitham K AlRabiah, Mohammed S Almousa, Ahmed Bari, Hamad M . 2019

Thiouracil, 2-sulfanylidene-1H-pyrimidin-4-one, has been used as anti-thyroid, coronary vasodilator, and in congestive heart failure. It was found to cause agranulocytosis and it is suspected to be teratogenic and carcinogenic. Owing to its high frequency of adverse reactions, especially agranulocytosis, its use was abandoned in favor of other, less toxic drugs, such as propylthiouracil and methimazole. Thiouracil refers both to a specific molecule consisting of a sulfated uracil and a family of molecules based upon the structure. An important member of this family is propylthiouracil, which is a thiourea antithyroid drug that acts by blocking the production of thyroid hormones; it also inhibits the peripheral deiodination of thyroxine to tri-iodothyronine. This profile is prepared to discuss and explain physical and chemical properties, proprietary and nonproprietary names of thiouracil and propylthiouracil. It also includes uses and applications, methods of preparation, thermal and spectral behavior and methods of analysis. In addition, metabolism, excretion and pharmacology of propylthiouracil are also discussed.

الصفحات
293-331
مزيد من المنشورات
publications

Heterocyclic chemistry is a broad branch of organic chemistry that contributes to almost one-third of all recent publications in the field, and it is becoming a more important subject for research…

بواسطة Siddique Akber Ansari , Hamad M. Alkahtani
2023
تم النشر فى:
Elsevier
publications

A method of making a pyrazole compound includes mixing a diazonium salt with a reactant in the presence of a solvent, thereby coupling a diazo group of the diazonium salt to an α-carbon atom of…

بواسطة Samar A. Abubshait, Haya A. Abubshait, Sara Nabil Shaban, Asma Mohmmad Elsharif, Hamad M. Alkahtani, Fadilah Sfouq Aleanizy, M. Nasiruzzaman SHAIKH
2024
publications

Foretinib (GSK1363089, FTB) is a multikinase inhibitor that inhibits multiple receptor tyrosine kinases, including vascular endothelial growth factor receptor-2 and mesenchymal–epithelial…

بواسطة Mohammed M Alanazi, Hamad M Alkahtani, Abdulrahman A Almehizia, Mohamed W Attwa, Ahmed H Bakheit, Hany W Darwish
2019